These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
362 related items for PubMed ID: 25015826
1. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma. Sui Q, Zhang J, Sun X, Zhang C, Han Q, Tian Z. J Immunol; 2014 Aug 15; 193(4):2016-23. PubMed ID: 25015826 [Abstract] [Full Text] [Related]
2. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC. Han Q, Wang Y, Pang M, Zhang J. J Exp Clin Cancer Res; 2017 Nov 07; 36(1):156. PubMed ID: 29115974 [Abstract] [Full Text] [Related]
3. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses. Salagianni M, Lekka E, Moustaki A, Iliopoulou EG, Baxevanis CN, Papamichail M, Perez SA. J Immunol; 2011 Mar 15; 186(6):3327-35. PubMed ID: 21317394 [Abstract] [Full Text] [Related]
4. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L. J Exp Med; 2005 Oct 17; 202(8):1075-85. PubMed ID: 16230475 [Abstract] [Full Text] [Related]
5. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Ohira M, Ohdan H, Mitsuta H, Ishiyama K, Tanaka Y, Igarashi Y, Asahara T. Transplantation; 2006 Dec 27; 82(12):1712-9. PubMed ID: 17198265 [Abstract] [Full Text] [Related]
6. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo. Jiang W, Zhang C, Tian Z, Zhang J. Immunobiology; 2014 Jul 27; 219(7):547-53. PubMed ID: 24721706 [Abstract] [Full Text] [Related]
7. Targeting blockage of STAT3 in hepatocellular carcinoma cells augments NK cell functions via reverse hepatocellular carcinoma-induced immune suppression. Sun X, Sui Q, Zhang C, Tian Z, Zhang J. Mol Cancer Ther; 2013 Dec 27; 12(12):2885-96. PubMed ID: 24107450 [Abstract] [Full Text] [Related]
8. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells. Seo N, Tokura Y, Takigawa M, Egawa K. J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122 [Abstract] [Full Text] [Related]
9. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3. Su Z, Ye X, Shang L. Yonsei Med J; 2019 Jan 01; 60(1):22-29. PubMed ID: 30554487 [Abstract] [Full Text] [Related]
10. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy. Yang B, Liu H, Shi W, Wang Z, Sun S, Zhang G, Hu Y, Liu T, Jiao S. Int Immunopharmacol; 2013 Oct 01; 17(2):198-204. PubMed ID: 23806302 [Abstract] [Full Text] [Related]
11. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H. Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839 [Abstract] [Full Text] [Related]
12. hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function. Jiang W, Zhang C, Tian Z, Zhang J. Gene Ther; 2013 Nov 01; 20(11):1062-9. PubMed ID: 23759701 [Abstract] [Full Text] [Related]
13. CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma. Xu C, Lu X, Liu W, Chen A, Meng G, Zhang H, Li B, Zhang Y, Wu J, Wei J. J Transl Med; 2018 May 21; 16(1):132. PubMed ID: 29784005 [Abstract] [Full Text] [Related]
14. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma. Kamiya T, Chang YH, Campana D. Cancer Immunol Res; 2016 Jul 21; 4(7):574-81. PubMed ID: 27197065 [Abstract] [Full Text] [Related]
15. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells. Sprinzl MF, Reisinger F, Puschnik A, Ringelhan M, Ackermann K, Hartmann D, Schiemann M, Weinmann A, Galle PR, Schuchmann M, Friess H, Otto G, Heikenwalder M, Protzer U. Hepatology; 2013 Jun 21; 57(6):2358-68. PubMed ID: 23424039 [Abstract] [Full Text] [Related]
16. Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. Elinav E, Abd-Elnabi A, Pappo O, Bernstein I, Klein A, Engelhardt D, Rabbani E, Ilan Y. J Hepatol; 2006 Mar 21; 44(3):529-36. PubMed ID: 16310278 [Abstract] [Full Text] [Related]
17. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Armeanu S, Krusch M, Baltz KM, Weiss TS, Smirnow I, Steinle A, Lauer UM, Bitzer M, Salih HR. Clin Cancer Res; 2008 Jun 01; 14(11):3520-8. PubMed ID: 18519785 [Abstract] [Full Text] [Related]
18. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma. Zhao J, Lin W, Cao Z, Liu L, Zhuang Q, Zhong X, Hong Z, Peng J. Oncol Rep; 2013 Sep 01; 30(3):1309-14. PubMed ID: 23828071 [Abstract] [Full Text] [Related]
19. miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression. Sun X, Zhang J, Hou Z, Han Q, Zhang C, Tian Z. Cell Cycle; 2015 Sep 01; 14(2):243-52. PubMed ID: 25607648 [Abstract] [Full Text] [Related]
20. Transforming growth factor-beta expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. Su HC, Ishikawa R, Biron CA. J Immunol; 1993 Nov 01; 151(9):4874-90. PubMed ID: 8409446 [Abstract] [Full Text] [Related] Page: [Next] [New Search]